Molecular Diagnostics
News on lab-developed tests and emerging diagnostic technologies.
The data, while limited, indicate that the firm's blood-only assay may be able to match the performance of existing commercial tissue-informed competitors.
In Brief This Week:Â Cleveland Diagnostics, Genprex, Viome
News items for the week of May 3, 2021.Â
The firm continues to pursue new applications for its multiomics machine learning technology, with recent data exploring immunotherapy response prediction.
Genetic Testing Challenges in Oncology: BRCA1-Positive Patient Told Paternal Cancer Risk Unimportant
A case series in partnership with My Gene Counsel to highlight the challenges genetics professionals and oncologists are grappling with as genetic testing is increasingly used in patient care.
Although genetic screening plus surveillance for children with certain genetic variants could reduce cancer deaths by 7.8 percent before age 20, health systems may not find such programs cost effective.